Get started
Author

Amy E. Marriott

Observed names: A E Marriott, A. E. Marriott, Amy E Marriott, Amy Marriott, Marriott, Amy, Marriott, Amy E.
ORCID: 0000-0002-4806-9539
Observed ORCID: 0000-0002-4806-9539
OpenAlex ID: A5000458896
In vitro and in vivo preclinical venom inhibition assays identify metalloproteinase inhibiting drugs as potential future treatments for snakebite envenoming by Dispholidus typus
2022 · Stefanie K. Menzies, Rachel H. Clare, et al. · Toxicon X · 50
PDF
Nanobody-based recombinant antivenom for cobra, mamba and rinkhals bites
2025 · Shirin Ahmadi, Nick J. Burlet, et al. · Nature · 48
Tetracyclines improve experimental lymphatic filariasis pathology by disrupting interleukin-4 receptor–mediated lymphangiogenesis
2021 · Julio Furlong-Silva, Stephen D. Cross, et al. · Journal of Clinical Investigation · 39
PDF
Sequential Infection with Influenza A Virus Followed by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Leads to More Severe Disease and Encephalitis in a Mouse Model of COVID-19
2024 · Jordan J. Clark, Rebekah Penrice-Randal, et al. · Viruses · 28
Wolbachia depletion blocks transmission of lymphatic filariasis by preventing chitinase-dependent parasite exsheathment
2022 · Shannon Quek, Darren A. N. Cook, et al. · Proceedings of the National Academy of Sciences · 26
Novel anti-Wolbachia drugs, a new approach in the treatment and prevention of veterinary filariasis?
2020 · Joseph D. Turner, Amy E. Marriott, et al. · Veterinary Parasitology · 25
Eosinophil-Mediated Immune Control of Adult Filarial Nematode Infection Can Proceed in the Absence of IL-4 Receptor Signaling
2020 · Nicolas Pionnier, Hanna Sjoberg, et al. · The Journal of Immunology · 22
PDF
Improving in vivo assays in snake venom and antivenom research: A community discussion
2024 · Amy E Marriott, Nicholas R Casewell, et al. · F1000Research · 21
Molecular dissection of cobra venom highlights heparinoids as an antidote for spitting cobra envenoming
2024 · Tian Y. Du, Steven R. Hall, et al. · Science Translational Medicine · 19
PDF
African polyvalent antivenom can maintain pharmacological stability and ability to neutralise murine venom lethality for decades post-expiry: evidence for increasing antivenom shelf life to aid in alleviating chronic shortages
2024 · Gabriela Solano, Sinead Cunningham, et al. · BMJ Global Health · 16
PDF
Structural Requirements for Dihydrobenzoxazepinone Anthelmintics: Actions against Medically Important and Model Parasites: Trichuris muris , Brugia malayi , Heligmosomoides polygyrus , and Schistosoma mansoni
2021 · Frederick A. Partridge, Carole J.R. Bataille, et al. · ACS Infectious Diseases · 16
Dirofilariasis mouse models for heartworm preclinical research
2023 · A E Marriott, J L Dagley, et al. · Frontiers in Microbiology · 15
PDF
Validation of ultrasound bioimaging to predict worm burden and treatment efficacy in preclinical filariasis drug screening models
2018 · Amy E. Marriott, Hanna Sjoberg, et al. · Scientific Reports · 10
PDF
Identification of DC-174 as a Novel Hydroxamic Precandidate for the Development of an Oral Snakebite Treatment
2026 · Daniel J. W. Chong, Laura-Oana Albulescu, et al. · Journal of Medicinal Chemistry · 9
Combinations of the azaquinazoline anti-Wolbachia agent, AWZ1066S, with benzimidazole anthelmintics synergise to mediate sub-seven-day sterilising and curative efficacies in experimental models of filariasis
2024 · Shrilakshmi Hegde, Amy E. Marriott, et al. · Frontiers in Microbiology · 9
PDF
NKp46+ natural killer cells develop an activated/memory-like phenotype and contribute to innate immunity against experimental filarial infection
2022 · Nicolas Pionnier, Julio Furlong-Silva, et al. · Frontiers in Immunology · 9
PDF
Handheld Point-of-Care Devices for Snakebite Coagulopathy: A Scoping Review
2024 · Michael Abouyannis, Amy E. Marriott, et al. · Thrombosis and Haemostasis · 7
PDF
Complying with ARRIVE 2.0: Reporting essentials for animal models of envenoming therapeutic efficacy testing
2025 · Amy E. Marriott, Stuart Ainsworth · Toxicon · 4
Plug and play virus-like particles for the generation of anti-toxin antibodies
2024 · Rebecca J. Edge, Amy E. Marriott, et al. · Toxicon X · 4
PDF
A mouse infection model and long-term lymphatic endothelium co-culture system to evaluate drugs against adult Brugia malayi
2022 · Amy E. Marriott, Julio Furlong Silva, et al. · PLoS neglected tropical diseases · 4
PDF
Structural requirements for dihydrobenzoxazepinone anthelmintics: actions against medically important and model parasites - Trichuris muris , Brugia malayi , Heligmosomoides polygyrus and Schistosoma mansoni
2020 · Frederick A Partridge, Carole JR Bataille, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 4
PDF
Preclinical evaluation of the neutralising efficacy of three antivenoms against the venoms of the recently taxonomically partitioned E. ocellatus and E. romani
2025 · Rebecca J. Edge, Amy E. Marriott, et al. · PLoS neglected tropical diseases · 3
PDF
Small molecule therapeutics for neutralising venom toxins – a drug discovery approach
2024 · Laura-Oana Albulescu, Adam Westhorpe, et al. · Toxicon · 2
Welcome to online-only production of Parasitology and future-proofing of the journal's academic standards
2021 · J. R. Stothard, S. Ainsworth, et al. · Parasitology · 2
PDF
Animal models in venom and antivenom research: The need to align academic discovery with manufacturing and regulatory expectations
2026 · Stuart Ainsworth, Nicholas R. Casewell, et al. · PLoS neglected tropical diseases · 1
Works count: 32
Citation count: 394
H-index: 12
I10-index: 13
Year
Topic
Type